Evidence map›Paper›PMID 38396489›Full record

ArticleDiagnostics (Basel, Switzerland)2024

Monocyte Chemoattractant Protein-1 (MCP-1), Activin-A and Clusterin in Children and Adolescents with Obesity or Type-1 Diabetes Mellitus.

Eirini Kostopoulou, Dimitra Kalavrizioti, Panagiota Davoulou, Evangelos Papachristou, Xenophon Sinopidis, Sotirios Fouzas, Theodore Dassios, Despoina Gkentzi, Stavroula Ioanna Kyriakou, Ageliki Karatza and 5 more

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Eirini KostopoulouDivision of Pediatric Endocrinology, Department of Pediatrics, University Hospital of Patras, School of Medicine, University of Patras, 26504 Patras, Greece.ORCID 0000-0002-7051-7537
Dimitra KalavriziotiDepartment of Nephrology and Kidney Transplantation, University Hospital of Patras, School of Medicine, University of Patras, 26504 Patras, Greece.
Panagiota DavoulouDepartment of Nephrology and Kidney Transplantation, University Hospital of Patras, School of Medicine, University of Patras, 26504 Patras, Greece.
Evangelos PapachristouDepartment of Nephrology and Kidney Transplantation, University Hospital of Patras, School of Medicine, University of Patras, 26504 Patras, Greece.
Xenophon SinopidisDepartment of Pediatric Surgery, University Hospital of Patras, School of Medicine, University of Patras, 26504 Patras, Greece.ORCID 0000-0002-0878-0668
Sotirios FouzasDepartment of Pediatrics, University Hospital of Patras, School of Medicine, University of Patras, 26504 Patras, Greece.ORCID 0000-0001-7617-9076
Theodore DassiosDepartment of Pediatrics, University Hospital of Patras, School of Medicine, University of Patras, 26504 Patras, Greece.
Despoina GkentziDepartment of Pediatrics, University Hospital of Patras, School of Medicine, University of Patras, 26504 Patras, Greece.
Stavroula Ioanna KyriakouDepartment of Pediatric Surgery, University Hospital of Patras, School of Medicine, University of Patras, 26504 Patras, Greece.
Ageliki KaratzaDepartment of Pediatrics, University Hospital of Patras, School of Medicine, University of Patras, 26504 Patras, Greece.
Gabriel DimitriouDepartment of Pediatrics, University Hospital of Patras, School of Medicine, University of Patras, 26504 Patras, Greece.
Dimitrios GoumenosDepartment of Nephrology and Kidney Transplantation, University Hospital of Patras, School of Medicine, University of Patras, 26504 Patras, Greece.
Bessie E SpiliotisDivision of Pediatric Endocrinology, Department of Pediatrics, University Hospital of Patras, School of Medicine, University of Patras, 26504 Patras, Greece.ORCID 0000-0001-7922-4012
Panagiotis PlotasDepartment of Speech and Language Therapy, School of Health Rehabilitation Sciences, University of Patras, 26504 Patras, Greece.ORCID 0000-0001-5514-7083
Marios PapasotiriouDepartment of Nephrology and Kidney Transplantation, University Hospital of Patras, School of Medicine, University of Patras, 26504 Patras, Greece.ORCID 0000-0001-9375-989X
University of Patras · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammation plays a crucial role in diabetes and obesity through macrophage activation. Macrophage chemoattractant protein-1 (MCP-1), activin-A, and clusterin are chemokines with known roles in diabetes and obesity. The aim of this study is to investigate their possible diagnostic and/or early prognostic values in children and adolescents with obesity and type-1 diabetes mellitus (T1DM).

methodsWe obtained serum samples from children and adolescents with a history of T1DM or obesity, in order to measure and compare MCP-1, activin-A, and clusterin concentrations.

resultsForty-three subjects were included in each of the three groups (controls, T1DM, and obesity). MCP-1 values were positively correlated to BMI z-score. Activin-A was increased in children with obesity compared to the control group. A trend for higher values was detected in children with T1DM. MCP-1 and activin-A levels were positively correlated. Clusterin levels showed a trend towards lower values in children with T1DM or obesity compared to the control group and were negatively correlated to renal function.

conclusionsThe inflammation markers MCP-1, activin-A, and clusterin are not altered in children with T1DM. Conversely, obesity in children is positively correlated to serum MCP-1 values and characterized by higher activin-A levels, which may reflect an already established systematic inflammation with obesity since childhood.

Indexed as

activin-Aadolescentschildrenclusterindiagnosismonocyte chemoattractant protein-1 (MCP-1)obesityprognosistype-1 diabetes mellitus (T1DM)

Identifiers

PMID38396489
PMCPMC10887959
OpenAlexW4391961742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.